These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 17563712)

  • 41. Novel biomimetic and bioactive silicones.
    Gorman SP; Woolfson AD
    Med Device Technol; 2002 Sep; 13(7):14-5. PubMed ID: 12397826
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Multivesicular emulsion: a novel, controlled-release delivery system for topical dermatological agents.
    Bikowski J; Shroot B
    J Drugs Dermatol; 2006; 5(10):942-6. PubMed ID: 17373142
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Swelling of silicone.
    Wiwanitkit V
    Med Eng Phys; 2010 Jun; 32(5):542; author reply 543. PubMed ID: 20226711
    [No Abstract]   [Full Text] [Related]  

  • 44. Nanoparticle infiltration to prepare solvent-free controlled drug delivery systems.
    Rodríguez-Cruz IM; Domínguez-Delgado CL; Escobar-Chávez JJ; Leyva-Gómez G; Ganem-Quintanar A; Quintanar-Guerrero D
    Int J Pharm; 2009 Apr; 371(1-2):177-81. PubMed ID: 19150491
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Periodontal muco-adhesive formulations for the treatment of infectious periodontal diseases.
    Pattnaik S; Panigrahi L; Murthy RS
    Curr Drug Deliv; 2007 Oct; 4(4):303-23. PubMed ID: 17979651
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Applications of supercritical CO2 in the fabrication of polymer systems for drug delivery and tissue engineering.
    Davies OR; Lewis AL; Whitaker MJ; Tai H; Shakesheff KM; Howdle SM
    Adv Drug Deliv Rev; 2008 Feb; 60(3):373-87. PubMed ID: 18069079
    [TBL] [Abstract][Full Text] [Related]  

  • 47. New spray congealing atomizer for the microencapsulation of highly concentrated solid and liquid substances.
    Albertini B; Passerini N; Pattarino F; Rodriguez L
    Eur J Pharm Biopharm; 2008 May; 69(1):348-57. PubMed ID: 17962005
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Lipids and polymers in pharmaceutical technology: Lifelong companions.
    Siepmann J; Faham A; Clas SD; Boyd BJ; Jannin V; Bernkop-Schnürch A; Zhao H; Lecommandoux S; Evans JC; Allen C; Merkel OM; Costabile G; Alexander MR; Wildman RD; Roberts CJ; Leroux JC
    Int J Pharm; 2019 Mar; 558():128-142. PubMed ID: 30639218
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Overview of drug product development.
    Lee KM
    Curr Protoc Pharmacol; 2002 Feb; Chapter 7():Unit7.3. PubMed ID: 21959767
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Nanostructured novel carrier for topical application.
    Guglielmini G
    Clin Dermatol; 2008; 26(4):341-6. PubMed ID: 18691513
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Formulation of lipid-based delivery systems for oral administration: materials, methods and strategies.
    Pouton CW; Porter CJ
    Adv Drug Deliv Rev; 2008 Mar; 60(6):625-37. PubMed ID: 18068260
    [TBL] [Abstract][Full Text] [Related]  

  • 52. New challenges for pharmaceutical formulations and drug delivery systems characterization using isothermal titration calorimetry.
    Bouchemal K
    Drug Discov Today; 2008 Nov; 13(21-22):960-72. PubMed ID: 18617012
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Glucocorticoid containing extemporaneous formulations. Rational for use in dermatology].
    Högger P
    Pharm Unserer Zeit; 2010 Jul; 39(4):294-9. PubMed ID: 20589803
    [No Abstract]   [Full Text] [Related]  

  • 54. Topical product design and extemporaneous compounding in dermatology.
    Krochmal L; Patel B
    Adv Dermatol; 1992; 7():231-52; discussion 253. PubMed ID: 1739582
    [No Abstract]   [Full Text] [Related]  

  • 55. In-vitro and in-vivo evaluation of enteric-coated starch-based pellets prepared via extrusion/spheronisation.
    Dukić-Ott A; De Beer T; Remon JP; Baeyens W; Foreman P; Vervaet C
    Eur J Pharm Biopharm; 2008 Sep; 70(1):302-12. PubMed ID: 18579353
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Preparation of honokiol-loaded chitosan microparticles via spray-drying method intended for pulmonary delivery.
    Li X; Guo Q; Zheng X; Kong X; Shi S; Chen L; Zhao X; Wei Y; Qian Z
    Drug Deliv; 2009 Apr; 16(3):160-6. PubMed ID: 19514976
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evaluation of in vitro tests to assess the efficacy of formulations as topical skin protectants against organophosphorus compounds.
    Millerioux J; Cruz C; Bazire A; Polly V; Lallement G; Lefeuvre L; Josse D
    Toxicol In Vitro; 2009 Feb; 23(1):127-33. PubMed ID: 18951968
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Recent advances in developing ophthalmic formulations: a patent review.
    Lu GW
    Recent Pat Drug Deliv Formul; 2010 Jan; 4(1):49-57. PubMed ID: 19807679
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Gel formation in systems composed of drug containing catanionic vesicles and oppositely charged hydrophobically modified polymer.
    Dew N; Edwards K; Edsman K
    Colloids Surf B Biointerfaces; 2009 May; 70(2):187-97. PubMed ID: 19167869
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Rheological and functional characterization of new antiinflammatory delivery systems designed for buccal administration.
    Perioli L; Pagano C; Mazzitelli S; Rossi C; Nastruzzi C
    Int J Pharm; 2008 May; 356(1-2):19-28. PubMed ID: 18258393
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.